Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-25 @ 3:00 AM
NCT ID:
NCT03803033
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years old;
* with at least one chronic disease, defined as a condition requiring prolonged management for a minimum of 3 months;
* living in Jordan for the past year;
* intention to remain in Jordan for the 3-month study duration;
* met at least one of the following criteria:
* taking ≥5 medications, taking ≥12 doses a day, discharged from the hospital within the past 4 weeks, exposed to significant changes in medication regimens within the past 3 months, demonstrating symptoms of potential adverse drug reactions, or demonstrating a poor therapeutic response to medication therapy. A significant change to medication regimen was defined as discontinuing a medication, starting new medications, or stepping up because of actual or potential therapy failure or guideline recommendations. A poor therapeutic response was defined as persistence of symptoms despite treatment.
Exclusion Criteria:
* Patients who don't have a chronic disease
* Cognitive or sensory impairment that may prevent conducting the interview
* Pregnant patients
* Patients who are planning to travel within the next 3 months after the baseline visit to the clinic
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03803033
Study Brief:
Protocol Section:
NCT03803033